Chaplain-clinician PEACE spiritual care for people with advanced cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center pilot uses a chaplain-clinician delivered PEACE intervention (Perception, Exploring, Addressing, Compassionate Connection, Embracing) in patients with advanced cancer seen by the supportive/palliative care mobile team at MD Anderson. Phase 1 examines feasibility (≥70% participation in all sessions) and acceptability (≥70% satisfied and ≥70% would recommend) in a single-arm cohort. Phase 2 examines within-group change on a key Religious Beliefs in End-of-Life Medical Care (RBEC) item about accepting every possible medical treatment for faith reasons, comparing PEACE participants and usual care over a short follow-up (baseline to ~2 days post-intervention). Eligible participants are English-speaking adults with advanced cancer, Karnofsky performance status ≥30%, intact cognition, and who endorse religious beliefs that influence treatment decisions.

Why it matters

Who can join: the full rules

Eligibility Criteria

1. Participants with advanced cancer (locally advanced, metastatic, recurrent, or incurable) seen by the participant supportive/palliative care mobile team at MD Anderson Cancer Center.
2. Respond "somewhat to A great deal" to the question in the RBEC questionnaire "I will accept every possible medical treatment because my faith tells me to do everything I can to stay alive longer".
3. Participant s aged 18 years or over.
4. Karnofsky performance status ≥30% at time of inclusion into study.
5. Normal cognitive status as determined by the supportive care clinicians based on the ability to understand the nature of the study and consent process.
6. Only English-speaking, as determined by their ability to understand the informed consent, the intervention, and the assessment tools.

Where it's running

• MD Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Marvin Delgado Guay, MD — M.D. Anderson Cancer Center
• Study coordinator: Marvin Delgado Guay, MD
• Email: marvin.delgado@mdanderson.org
• Phone: 713-745-8190

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Concise coaching to guide decisions for advanced cancer patients considering palliative procedures

  A coaching program delivered by lay providers will test whether it helps adults with advanced cancer make better, patient-aligned decisions about palliative surgeries or similar interventions.

  Recruiting Singapore General Hospital · Singapore · NCT07789093

• Primary Palliative Care: A Feasibility Project for Family Health Units

  This feasibility trial tests a GP training program plus a structured 12-week palliative-care visit plan to see if it can be carried out in primary care for adults with advanced illness.

  Recruiting University of Coimbra · Coimbra and 1 other locations · NCT07737899

• Virtual Group Resilient Living for Advanced Cancer

  A group-based online program tests whether seven weekly sessions can reduce anxiety and fatigue and improve quality of life for adults with advanced cancer.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07659158

• IV contrast-enhanced CBCT with HyperSight for image guidance in advanced cancer radiotherapy

  This study tests whether giving IV contrast during cone-beam CT helps doctors see the tumor better during radiotherapy in people with advanced cancer.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07648160

• Single-session celiac plexus SBRT using a simulation-free adaptive workflow for cancer-related pain

  A pilot test to see if a one-day, simulation-free adaptive radiotherapy process can safely deliver celiac plexus SBRT to adults with advanced pancreatic or other cancers.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07636382

• UI-102 in advanced cancers (phase 1/2) first-in-human

  A first-in-human study tests UI-102, given to adults with advanced solid tumors to see if it is safe and shows signs of benefit.

  Recruiting at 3 sites Phase 1/2 United Immunity, co., Ltd. · Dallas, Texas and 2 other locations · NCT07605962

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.